Literature DB >> 22075667

Molecular, kinetic and thermodynamic characterization of Mycobacterium tuberculosis orotate phosphoribosyltransferase.

Ardala Breda1, Leonardo Astolfi Rosado, Daniel Macedo Lorenzini, Luiz Augusto Basso, Diógenes Santiago Santos.   

Abstract

Tuberculosis (TB) is a chronic infectious disease caused mainly by Mycobacterium tuberculosis. The worldwide emergence of drug-resistant strains, the increasing number of infected patients among immune compromised populations, and the large number of latent infected individuals that are reservoir to the disease have underscored the urgent need of new strategies to treat TB. The nucleotide metabolism pathways provide promising molecular targets for the development of novel drugs against active TB and may, hopefully, also be effective against latent forms of the pathogen. The orotate phosphoribosyltransferase (OPRT) enzyme of the de novo pyrimidine synthesis pathway catalyzes the reversible phosphoribosyl transfer from 5'-phospho-α-D-ribose 1'-diphosphate (PRPP) to orotic acid (OA), forming pyrophosphate and orotidine 5'-monophosphate (OMP). Here we describe cloning and characterization of pyrE-encoded protein of M. tuberculosis H37Rv strain as a homodimeric functional OPRT enzyme. The M. tuberculosis OPRT true kinetic constants for forward reaction and product inhibition results suggest a Mono-Iso Ordered Bi-Bi kinetic mechanism, which has not been previously described for this enzyme family. Absence of detection of half reaction and isothermal titration calorimetry (ITC) data support the proposed mechanism. ITC data also provided thermodynamic signatures of non-covalent interactions between substrate/product and M. tuberculosis OPRT. These data provide a solid foundation on which to base target-based rational design of anti-TB agents and should inform us how to better design inhibitors of M. tuberculosis OPRT.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22075667     DOI: 10.1039/c1mb05402c

Source DB:  PubMed          Journal:  Mol Biosyst        ISSN: 1742-2051


  7 in total

1.  Wild-type phosphoribosylpyrophosphate synthase (PRS) from Mycobacterium tuberculosis: a bacterial class II PRS?

Authors:  Ardala Breda; Leonardo K B Martinelli; Cristiano V Bizarro; Leonardo A Rosado; Caroline B Borges; Diógenes S Santos; Luiz A Basso
Journal:  PLoS One       Date:  2012-06-20       Impact factor: 3.240

2.  Structural investigations on orotate phosphoribosyltransferase from Mycobacterium tuberculosis, a key enzyme of the de novo pyrimidine biosynthesis.

Authors:  Stefano Donini; Davide M Ferraris; Riccardo Miggiano; Alberto Massarotti; Menico Rizzi
Journal:  Sci Rep       Date:  2017-04-26       Impact factor: 4.379

Review 3.  Recent Advances of Pyridinone in Medicinal Chemistry.

Authors:  Shibo Lin; Chun Liu; Xiaotian Zhao; Xiao Han; Xuanhao Li; Yongqin Ye; Zheyu Li
Journal:  Front Chem       Date:  2022-03-23       Impact factor: 5.221

4.  Kinetic Characterization and Inhibition of Trypanosoma cruzi Hypoxanthine-Guanine Phosphoribosyltransferases.

Authors:  Kayla Glockzin; Demetrios Kostomiris; Yacoba V T Minnow; Kajitha Suthagar; Keith Clinch; Sinan Gai; Joshua N Buckler; Vern L Schramm; Peter C Tyler; Thomas D Meek; Ardala Katzfuss
Journal:  Biochemistry       Date:  2022-09-15       Impact factor: 3.321

5.  Comparative genomics of koala, cattle and sheep strains of Chlamydia pecorum.

Authors:  Nathan L Bachmann; Tamieka A Fraser; Claire Bertelli; Martina Jelocnik; Amber Gillett; Oliver Funnell; Cheyne Flanagan; Garry S A Myers; Peter Timms; Adam Polkinghorne
Journal:  BMC Genomics       Date:  2014-08-08       Impact factor: 3.969

Review 6.  Targeting Genome Integrity in Mycobacterium Tuberculosis: From Nucleotide Synthesis to DNA Replication and Repair.

Authors:  Riccardo Miggiano; Castrese Morrone; Franca Rossi; Menico Rizzi
Journal:  Molecules       Date:  2020-03-07       Impact factor: 4.411

7.  Characterization of adenine phosphoribosyltransferase (APRT) activity in Trypanosoma brucei brucei: Only one of the two isoforms is kinetically active.

Authors:  Kayla Glockzin; Thomas D Meek; Ardala Katzfuss
Journal:  PLoS Negl Trop Dis       Date:  2022-02-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.